A new drug called Letairis (ambrisentan) plus new guidelines are updating treatment for pulmonary arterial hypertension

Please see the August 2012 FDA warning concerning the use of Revatio in children with PAH A new drug called Letairis (ambrisentan) plus new guidelines are updating treatment for pulmonary arterial hypertension. ...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login